# First personalised cancer vaccine cuts risk of disease returning in major trial

> **Open Intelligence Dossier** · First detected: 2026-10-23 14:20 UTC · Category: Business

## Executive Summary
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"First personalised cancer vaccine cuts risk of disease returning in major trial" is generating significant coverage in the Business category, with 8 articles from 6 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, Yahoo, Bloomberg.com and New Scientist. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| NBC News | Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxOZGd4TmxtWGtzQTdiUlllRjVaWUFlNmpESnN4bW80RXJudFhlb1dMbFlmTTNSVVBXWlcwS0xqaDlIcGtwYThmOGx0azItWlRIQ3gzU2ZtOE02eUNKQTJKR25YUTVMUE94NW14RFI5WGQtbEpOaU5BYzl4ZENFRzZrX0JrTGZQQUpacl9XelFUWDIxNU9GbmFGWnhhRkRjTHZSNUFON3lEY2U3YXhoXzlQRExfdl9jYk81bWc?oc=5) |
| CNBC | Doctors call Moderna, Merck's cancer vaccine data a major advancement — even as stocks fall | [Source Link](https://news.google.com/rss/articles/CBMiekFVX3lxTFBic1BjZTVUN190b0lyOGkyTmx1UDlvaGpiY3psNXlwOEFpQXIxZTZxOU1FZWQzRlVjTS04T0c0ZXJ2Wm9rVWk4OTJqT25kcXpaS2xpMTlnWjcwQWlMSzZHWGxKTkJaY0NjNGRuYWExSGw3dng1RjQwV0pn0gF_QVVfeXFMTUpnRDVLVmItbUdwM01ncEZJWWZOMzRqMTJJY1R6RTBIcHllTnQ5OEV3eHhiRmk1UTg5Sk9jNFgyUk95RTVSSk9PclU1WU5ORG54RnV6NVM4SmZiRnEtZ1NDaGhwUWZNdHlRcXZ0Tk5KOGYyOUpYUk1COG1zOUExWQ?oc=5) |
| Yahoo | Cancer vaccine reduces melanoma from returning by 42%, data shows | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxNTm0zanNmOGVfMkhtOTdOeEhvemhYVXU5dFRjWEYtZkhZX3hxS0RsU3lVaktZSzNIWEtnNVN6bVFhSHhOcS1QSmNBVU9lS0dfQk9xU3M4d1hTamF5ZzRJV0ZmN0w2bVlnWGk5eV9xUldjbm1wY2dkM0lGalRaOTUzQS15TGdCLVV0SGVsQ2lvMm5RbGtRd29hY3VycGNPckZfeXc?oc=5) |
| Investor's Business Daily | Will These Nuances Undo Merck And Moderna's Cancer Vaccine? | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPTS1mNXBmbHBQeGdTbHg2b1NFN1FGVFVQTXNLbGpGOUluVjNUN3h1NDZvXzR4dWQzckwzMjA5Mk5aSlk3RTh4Ymp4OE5JczNIcmJFUlJlRlNEcXFVMWZBeFJjai05Qmd5ZTdjM2Jxa2E2Y1VVb2JXY1dEd0FvN2VXb0t6OV9wcUhreUhr?oc=5) |
| Yahoo Finance | Moderna trims losses as investors digest melanoma vaccine trial data | [Source Link](https://news.google.com/rss/articles/CBMizAFBVV95cUxPR2FLaVVoRTVSeVNnX1ZwY21VU1hBWTF0eTU1UTJxejUxNEhxRGw1MkNzcU16VzVpZk5wVjc0TmhxY21taHMwMlVKbGhJUmoxekwwN3VTM29BSW0zR2NzMS1mLU01Q2V5cEphR09FYlFnMl83eWhYMnFIc0hRN1c3cm9rV25jM0RKNXNSRUlKbWxZR1RQRU03Mldxc2Y0MWJ0YVlTSzZyMTUtaVNEQ0xmNzQycEF6UnJNeFE2bVoxbEJfQ1dLbUF0eHB2MW0?oc=5) |
| Yahoo | Personalized mRNA Vaccine Cuts Melanoma Death Or Recurrence Risk 42% | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxObm84bWdsVmw3bm5hdXZZOXpTaTF5ZVVyeFI2WUotYUNuTVA3UC1jR3FxajF3a0pCbjRHRF9ydzVIN1FXeEJ5c21vSUIxRnRVRUF4Z2o4QkNTSTJnbUdhcGVGVDNDN3p6Y1NjUUNLc3JuQkRVRVdwVHFpc2tyZWFxdFJUVjFnUk9JVDJ2WExzZEtVOGU2MW53UTR0MlotODg?oc=5) |
| Bloomberg.com | Oncologists Cheer Melanoma Data That Tanked Moderna’s Shares | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxOTlZNay05ZE1VbTNBVmZHT0ZMYzkxZ2VKOS10X1dKbVR6WU1kc2pLRk05aVZzU2txX3VqMlRQOXhXSW9iYWczN0NpQjJkN2dSRzhFVkVlNFFubUxFdUs5dTJMenBpM3cxSnJlQ28wTHJCYVNvRW5aSUpsUkFBS1dUbWIxRkhDSUhrc2E1bjZoUElKRGdqTEIzT2RzRC1lYUpWaE45U2djZDM5c0JxME1CVQ?oc=5) |
| Yahoo Finance | Moderna’s Stock Just Stumbled. Is It a Buy on the Dip? | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNUmV4cUpZNDFLeGNNU0VFVThaWnBsUVJjRmx0aGRsTk9fTmdZQmhDMU5sQ1p0QndrejF0ZFZvVVMzTVFScDRGSEhTQWVCamdXT2ktRWdTMnBaNm4yZGZDZ1N5T1Rya0lBMEdwcVRpOTRNZlR3M2U3cS1VeUR1VHh1MTBpaWF2NFB2Sk16MDZ0bXVCRF9XaHVRdFFtTEY?oc=5) |
| New Scientist | Personalised cancer vaccine expected to be approved next year | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcG9uaXJIbDdmSk4zMndXWDluOHZhNUk4MTdDVzdpMFRqc3VuNDhha0VQdG1HX3dUYWJQYzVuNGhYazFuUm9mN1V5alpaYWVxLWpUY09DQlo0ZGNlQXlGT2pHY3p0T05kdDc1eS1wT1Jmd2dfTHk5Rk5NeDN2elhvMm55OS0tR1RvbHpyNXZtbEl5XzNQbkFscmkxWTRkdGJtTWxIX2h3dTgybFE?oc=5) |
| Yahoo Finance | Moderna stock extends decline after leaked data on melanoma vaccine trial | [Source Link](https://news.google.com/rss/articles/CBMiygFBVV95cUxNc2pyRnBIUkh0TGw0cDBfM3RxcFdINnBFOVNqVHhWZTh3THY0ai1TdVZYTmhhMHliSThmNWRYcXpEaW1mWE5NdmN1VGhleE1JaFZrQW9DNFN1T3hRSHlTNzdxQ3RNcnZ1LTBCSHIzbnVEY3FFLVpJRHlyb0pwMzFhN3Rpd0xXRW1ya3JRMnpTWnM1aUtTN0d5VDRSS2RSaWdCVXhWVGx5bDlYZ3FEVmQ2dk5nMlRfNnEzY0RPWnFZUmVIc2tDbU5uTVFB?oc=5) |
| STAT | Pharmalittle: We're reading about a cancer vaccine, an experimental pancreatic cancer drug, and more | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxPak9FRjJmMl9DQ0Q2T0E3cUdldFBXX2lTdnVESDRRTnEwcDRSeUk5aXJlQ2NabTY1M0JNYmVudEVnR0Fva0tIbDFtVFR0RXlTUEpiYURiSFpCbV9aNFpQSGUzU2JRS0JyWU5USUk3Q1VKMFhDNEczVk5kczhnTGlqSmE1bG1nT1M3WHFlQkRaNGZlR2NWTGluZVpZdW9Ka0VGSk5TbkwyeWg0dHRCYXJVamNBUDBWaDQ?oc=5) |
| The New York Times | First-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients | [Source Link](https://news.google.com/rss/articles/CBMif0FVX3lxTE1jczI3bThhd0tzY1p0ZzlZQ2ViR2Q3V0dFaVNSa0hYQWRtNG8xLXItWW1tZFBZN3Q1WlRoSXhuVjVsMVlmUXVpLWM2c2hJVUlhQVRQREE1UlR1VnU0WWJZa3ExVDk2dTl4WnUwVEVaSVVHYzNhMTVqUFJlby1EMjA?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-23/first-personalised-cancer-vaccine-cuts-risk-of-disease-returning-in-major-trial*